Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00501358Unknown

Sleep Apnea and Tromboembolic Disease

Role: collaborator

NCT00477074Completed

Pulmonary and Systemic Hepatocyte Growth Factors in Patients With COPD

Role: collaborator

NCT00456651Not ApplicableUnknown

Sleep Apnea-Hypopnea Syndrome and the Pathogenesis of Obesity

Role: collaborator

NCT00456287Not ApplicableUnknown

Platelet Activation and Circadian Rhythms of Clotting-Fibrinolysis Factors in Patients With Sleep Apnea Syndrome

Role: collaborator

All 4 trials loaded